The best indicator for HCA Healthcare (HCA)
We backtested 20 indicators across daily, weekly and hourly charts on real HCA Healthcare (HCA) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
Donchian Midline
On the daily chart, this is the strongest risk-adjusted edge we found for HCA Healthcare (HCA) over ~15.2 years — trailing buy-and-hold by 6.1% CAGR.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | Donchian Midline ✓ | Daily | 14.0% | 0.67 | -33.6% | 44.7% | 199 | -6.1% |
| 2 | Donchian Midline ✓ | Weekly | 13.9% | 0.64 | -40.8% | 47.4% | 38 | -6.0% |
| 3 | RSI Trend (>50) ✓ | Weekly | 13.3% | 0.63 | -34.6% | 47.2% | 36 | -6.6% |
| 4 | CCI ✓ | Weekly | 8.7% | 0.62 | -24.9% | 86.7% | 15 | -11.1% |
| 5 | Money Flow Index ✓ | Daily | 11.0% | 0.6 | -39.5% | 58.8% | 17 | -9.1% |
| 6 | EMA 20/50 Cross ✓ | Daily | 11.9% | 0.59 | -41.7% | 51.6% | 31 | -8.1% |
| 7 | EMA-10 Trend ✓ | Daily | 11.6% | 0.59 | -40.0% | 44.2% | 317 | -8.5% |
| 8 | RSI Trend (>50) ✓ | Daily | 11.0% | 0.57 | -31.1% | 42.8% | 187 | -9.1% |
| 9 | CCI ✓ | Daily | 10.3% | 0.57 | -49.6% | 78.2% | 78 | -9.8% |
| 10 | MACD ✓ | Weekly | 10.0% | 0.54 | -44.7% | 51.6% | 31 | -9.8% |
| 11 | MACD ✓ | Daily | 9.9% | 0.52 | -44.5% | 45.6% | 147 | -10.2% |
| 12 | Williams %R | Weekly | 8.0% | 0.51 | -25.1% | 81.2% | 16 | -11.9% |
| 13 | Stochastic | Daily | 8.1% | 0.48 | -49.6% | 74.3% | 74 | -11.9% |
| 14 | Williams %R ✓ | Daily | 8.0% | 0.48 | -49.6% | 67.7% | 96 | -12.0% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For HCA Healthcare (HCA), Donchian Midline on the daily timeframe gave the best balance of return and risk in our test. It still trailed buy-and-hold on raw return — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.